Columbia MD/PhD student Deirdre Ricaurte is using new genomics methods to understand how prescription drugs disturb our gut microbiome and the health consequences of these “drug-bug” interactions.
Many Black Americans thought to have a high risk of developing kidney disease possess a genetic variant that eradicates the extra risk, a new study from Columbia researchers has found.
A new study that uncovers the original role of CRISPR’s scissors answers an evolutionary mystery and could lead to the discovery of better gene editing tools.
In the GUARDIAN study, the genomes of newborns are being scanned to identify children who have one of hundreds of treatable and preventable rare genetic conditions before symptoms emerge.
Researchers have found a way to identify disease-causing genetic mutations in the non-coding region of the genome, which has been uninterpretable until now.
New genetic findings should help researchers uncover how MacTel, a disease of the retina, develops and how to design therapies to prevent loss of vision.
Columbia and NewYork-Presbyterian research has shown that several genes implicated in rare forms of pediatric epilepsy also contribute to common forms of the disorder.
Columbia University researchers have created a user-friendly program that rapidly predicts which genes are implicated in an individual’s cancer and recommends treatments.
$4 million grant gives Columbia, Weill Cornell Medicine, NewYork-Presbyterian, and NYC Health + Hospitals key role in precision medicine cohort program.